Media Coverage

News featured in Nutrition Insight

Sabinsa’s Curcumin C3 Reduct ingredient has potential in oral care applications, according to a new clinical trial. The findings build on previous research and show beneficial outcomes for mouth and gum-related diseases.

Read More...


News featured in Happi.com

Sabinsa has published research building on evidence from a previous trial investigating the potential of Sabinsa’s Curcumin C3 Reduct ingredient in oral care applications.

Read More...


News featured in Wholefoods Magazine

A new study supports the use of Sabinsa’s Curcumin C3 Reduct as an oral care ingredient, according to a press release.

Read More...


News featured in Nutraceuticals World

A preliminary study on Canker sores suggests that anti-inflammatory curcumin metabolites reduce inflammation at the source.

Read More...

 

    VISIT US

  • Edifício Koerich Beiramar Office
    Avenida Mauro Ramos
    1970- Sala 705-Centro
    Florianópolis-SC
    Brasil CEP 88.020-302

  • +55 48 3206 3682
  • info@sabinsa.com.br

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.